News
Gene Therapy Stays on Market Despite FDA Request
Digest more
Sarepta has refused to suspend all dosing of its gene therapy for Duchenne muscular dystrophy, Elevidys, defying a clinical ...
Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.
2d
Investor's Business Daily on MSNThe FDA Will Reportedly Ask Sarepta To Stop Selling Elevidys. Shares Plummet.Sarepta stock crashed Friday on reports the FDA will ask the biotech company to stop shipments of its approved gene therapy, ...
Sarepta Therapeutics announced a layoff of 493 employees, including 80 in Franklin County, amid restructuring efforts and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results